Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
Penumbra, Inc. Reports Third Quarter 2025 Financial Results
04:05pm, Wednesday, 05'th Nov 2025
ALAMEDA, Calif. , Nov. 5, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2025.
The STORM-PE RCT data presented at the VIVA 2025 Conference showed PE patients treated with CAVT in combination with anticoagulation demonstrated significantly greater improvements in thrombus burden
AlphaQuest LLC Grows Holdings in Penumbra, Inc. $PEN
03:59am, Monday, 03'rd Nov 2025
AlphaQuest LLC grew its stake in Penumbra, Inc. (NYSE: PEN) by 237.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). T
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Penumbra, Inc. $PEN
05:12am, Saturday, 01'st Nov 2025
Sumitomo Mitsui Trust Group Inc. decreased its holdings in Penumbra, Inc. (NYSE: PEN) by 62.3% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commis
ALAMEDA, Calif. , Oct. 27, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced the results of the landmark STORM-PE randomized controlled trial (RCT), which found that the use of mechanical thr
Penumbra, Inc. (PEN) Presents at Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 Transcript
05:37am, Monday, 27'th Oct 2025
Penumbra, Inc. (NYSE:PEN ) Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 October 26, 2025 7:00 PM EDT Company Participants Adam Elsesser - Co-Founder, Chairman & CEO Shruthi Narayan
Can Penumbra's 'Landmark' Study Vs. Blood Thinners Change Guidelines?
05:00pm, Sunday, 26'th Oct 2025
Penumbra unveiled the results of a study on Sunday showing its device is superior to blood thinners in pulmonary embolism patients.
Penumbra, Inc. (NYSE:PEN) Given Average Recommendation of “Moderate Buy” by Analysts
01:42am, Friday, 24'th Oct 2025
Shares of Penumbra, Inc. (NYSE: PEN - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eighteen ratings firms that are presently covering the company, Marketbeat re
ITGR or PEN: Which Is the Better Value Stock Right Now?
12:40pm, Monday, 13'th Oct 2025
Investors interested in Medical - Instruments stocks are likely familiar with Integer (ITGR) and Penumbra (PEN). But which of these two companies is the best option for those looking for undervalued s
ALAMEDA, Calif. , Oct. 8, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host an investor event on Sunday, October 26, 2025 from 4:00-5:00 PM Pacific Time / 7:00-8:00 PM
TFX vs. PEN: Which Stock Should Value Investors Buy Now?
12:41pm, Wednesday, 24'th Sep 2025
Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks is more attractive to value investors?
Penumbra, Inc. (PEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
04:44pm, Tuesday, 09'th Sep 2025
Penumbra, Inc. (NYSE:PEN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 1:50 PM EDT Company Participants Adam Elsesser - Co-Founder, Chairman & CEO Shruthi Narayan - Presi
New Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile
09:00am, Tuesday, 09'th Sep 2025
Survey Conducted by the Get Out the Clot Campaign, an Initiative Focused on Identifying and Closing Gaps in Patient Care for Blood Clots ALAMEDA, Calif. , Sept. 9, 2025 /PRNewswire/ -- The American Ve
Penumbra, Inc. (PEN) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
12:28pm, Wednesday, 03'rd Sep 2025
Penumbra, Inc. (NYSE:PEN ) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 8:45 AM EDT Company Participants Adam Elsesser - Co-Founder, Chairman & CEO Shruthi Narayan - President
Why Is Penumbra (PEN) Up 5% Since Last Earnings Report?
12:36pm, Thursday, 28'th Aug 2025
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock?
